The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

The proportion of patients with amyotrophic lateral sclerosis caused by a genetic mutation might be less than 10% of all cases. However, the investigation of the mechanisms that lead to the loss of ...

The technology was created by Indu Navar, a former tech executive who turned grief into action after losing her husband to ...

The 25th anniversary celebration of the Wings Over Wall Street benefit will recognize ALS researchers and advocates.

Every 90 minutes, someone is diagnosed with amyotrophic lateral sclerosis (ALS), often called Lou Gehrig’s disease. On ...

David Doane of Bucksport has been a vocal advocate for legislation and research for amyotrophic lateral sclerosis, commonly ...

A Series in The Lancet Neurology provides state-of-the-art reviews covering clinical and scientific evidence on the four most common genetic subtypes of amyotrophic lateral sclerosis (ALS), caused by ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...

Anthony Senerchia, Pat Quinn and Pete Frates — three men living with amyotrophic lateral sclerosis — initiated the Ice Bucket ...